Identifying drug candidates to overcome resistance in tubo-ovarian cancer
Hovedveileder: Kjetil Taskén (OUS)
Medveileder: Fahri Saatcioglu (IBV), Mary-Ann Jallad (OUS), Katharina Bischof (OUS)
Eksaminatorer: Lina Prasmickaite (OUS), Pål Falnes (BV)